Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change	Volume
30/07/26	EUR 0.7180	-6.02%	37,632
28/07/26	EUR 0.7640	-15.11%	38,013
27/07/26	EUR 0.9000	+60.71%	109,397
24/07/26	EUR 0.5600	+47.37%	8,278
23/07/26	EUR 0.3800	0.00%	0

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris Other stock markets 01:55:00 30/07/26 am AEST			5-day change	1st Jan Change
0.7180 ^EUR	-6.02%		+88.95%	-17.28%

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.27M 2.68M 2.46M 4.61M 314M 4.73M 31.84M 12.45M 155M 12.29M 12.02M 536M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.5M 3.69M 3.39M 6.35M 431M 6.5M 43.8M 17.13M 213M 16.91M 16.54M 738M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
08/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
15/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
06/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

04/03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
26/02	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
10/12	Klarsen : ALKLA-Attribution gratuite de BSA	PU
09/12	Klarsen : ALKLA-ACTIVITE 3T2025	PU
28/11	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Stock

Stocks

ALKLA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Course Extremes

Managers and Directors: Klarsen

Latest insider transactions

Other IT Services & Consulting

Financials

Company Profile

Quotes

Income Statement and Estimates

24/07	Klarsen : ALKLA – Klarsen annonce la résolution amiable de son litige avec la société PADAM – 24 Juillet 2026
24/07	Klarsen : ALKLA-Résolution litige PADAM à l'amiable
22/07	KLARSEN : Rapport Financier Annuel 2025
22/07	Klarsen : Information réglementée – 2025
22/07	Klarsen : ALKLA-Annexe résultat 2025

1 day	-6.02%
1 week	+88.95%
Current month	+88.95%
1 month	+88.95%
3 months	+140.94%
6 months	-30.63%
Current year	-17.28%

1 week	0.38	0.9
1 month	0.38	0.9
Current year	0.22	1.18
1 year	0.22	1.18
3 years	0.22	4.03
5 years	0.22	4.03
10 years	0.11	5.4

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Jean-Luc Rivière BRD	Director/Board Member	-	26/06/2012
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014

Date	Insider	Type	Main position	Quantity	% Market Cap.
15/3/22	Parrou Julien	Buy		2,617	0.0790%
28/2/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,011	0.0909%
28/2/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	11,500	0.3471%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	-6.02%	+88.95%	-18.41%	-78.44%	2.88M
IBM	-0.49%	+10.05%	-13.71%	+57.05%	214B
ACCENTURE PLC	+5.17%	+23.61%	-37.91%	-45.26%	101B
SNOWFLAKE INC.	+4.64%	+5.64%	+29.32%	+59.19%	93.71B
TATA CONSULTANCY SERVICES LTD.	+2.03%	+10.15%	-20.55%	-27.08%	90.82B
RELX PLC	+1.48%	+17.11%	-26.16%	+9.15%	65.81B
INFOSYS LIMITED	+4.51%	+7.65%	-23.77%	-13.79%	46.87B
FUJITSU LIMITED	+3.89%	+16.17%	+19.56%	+112.43%	39.21B
HCL TECHNOLOGIES LIMITED	+1.95%	+8.46%	-8.31%	+21.82%	37.35B
NEC CORPORATION	+2.74%	+4.67%	+14.10%	+238.99%	36.38B
Average	+1.97%	+16.15%	-8.58%	+33.41%	72.53B
Weighted average by Cap.	+2.23%	+6.88%	-10.68%	+33.96%

	2023	2024
Net sales	5.03M 5.72M 4.69M 4.31M 8.06M 548M 8.26M 55.63M 21.76M 271M 21.47M 21.01M 937M	6.31M 7.18M 5.89M 5.41M 10.12M 688M 10.37M 69.85M 27.32M 340M 26.97M 26.38M 1.18B
Net income	2.75M 3.13M 2.57M 2.36M 4.41M 300M 4.52M 30.45M 11.91M 148M 11.75M 11.5M 513M	-47.76K -54.36K -44.59K -40.92K -76.59K -5.21M -78.48K -529K -207K -2.58M -204K -200K -8.91M
Net Debt	-634K -722K -592K -544K -1.02M -69.16M -1.04M -7.02M -2.75M -34.22M -2.71M -2.65M -118M	1.08M 1.23M 1.01M 926K 1.73M 118M 1.78M 11.96M 4.68M 58.3M 4.62M 4.52M 202M